Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Immuron Ltd changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 4 | 3 | −1 |
| Shares | 6.23K | 20.4K | +14.2K (+227.5%) |
| Value | $13.3K | $42.1K | +$28.8K (+216.1%) |
New holders (1)
Institutions that held Immuron Ltd at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Old Mission Capital LLC | 14,608 | $30.0K | 0.00% |
Sold out (2)
Institutions that held Immuron Ltd at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| BNP Paribas Arbitrage, SA | 51 | $109 |
| Global Wealth Management Investment Advisory, Inc. | 100 | $0 |